Table 4.
Association between LRRC19 mRNA and clinicopathological factors in CRC patients.
Characteristics | Total (N = 56) | LRRC19 mRNA | P value | |
---|---|---|---|---|
Low (n = 26) | High (n = 30) | |||
Age | 0.589 | |||
≤65 | 22 | 9 | 13 | |
>65 | 34 | 17 | 17 | |
| ||||
Gender | 0.278 | |||
Male | 33 | 13 | 20 | |
Female | 23 | 13 | 10 | |
| ||||
Tumor location | 0.399 | |||
Colon | 19 | 7 | 12 | |
Rectum | 37 | 19 | 18 | |
| ||||
Pathology stage | 0.104 | |||
I | 0 | 0 | 0 | |
II | 29 | 9 | 20 | |
III | 27 | 15 | 12 | |
| ||||
T stage | 0.038 | |||
T1 | 1 | 0 | 1 | |
T2 | 9 | 2 | 7 | |
T3 | 31 | 13 | 18 | |
T4 | 15 | 11 | 4 | |
| ||||
N stage | 0.047 | |||
N0 | 34 | 12 | 22 | |
N1 | 12 | 6 | 6 | |
N2 | 10 | 8 | 2 | |
| ||||
M stage | 0.211 | |||
M0 | 54 | 24 | 30 | |
M1 | 2 | 2 | 0 |